New Zealand Markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
42.49-0.44 (-1.02%)
At close: 04:00PM EDT
42.49 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close42.93
Open42.93
Bid42.42 x 200
Ask42.51 x 200
Day's range42.24 - 43.01
52-week range27.99 - 50.99
Volume179,079
Avg. volume354,450
Market cap3.206B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.73
Earnings date07 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est58.10
  • GlobeNewswire

    Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

    Phase 3 epilepsy program continues to progress with anticipated completion of patient enrollment in X-TOLE2 in late 2024 to early 2025 Successful “end-of-Phase 2” interactions with FDA in MDD; Phase 3 program on track to initiate in the second half of the year Azetukalner now the international nonproprietary name (INN) and United States adopted name (USAN) for XEN1101 Conference call at 4:30 pm ET today VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nas

  • GlobeNewswire

    Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

    VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV. Fireside Chat Presentation Details:Date:Wednesday, May 15, 2024Time:3:40 pm Pacific Time (6:40 pm Eastern Time)Webcast:Register herePresenters:Ian Mortimer, President and Chief Executive OfficerSherry A

  • GlobeNewswire

    Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

    VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY. Fireside Chat Presentation Details: Date:Tuesday, May 14, 2024Time:3:35 pm Eastern TimeWebcast:Register herePresenters:Ian Mortimer, President and Chief Executive OfficerSherry Aulin, Chief Fin